Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kite Pharma
Manufacturing
Gilead's Kite shortens Yescarta manufacturing time with FDA nod
The FDA has approved a manufacturing process that allows Gilead's Kite to shorten Yescarta's manufacturing time from an average of seven to five days.
Angus Liu
Jan 30, 2024 8:39am
FDA wants classwide boxed warning on existing CAR-Ts
Jan 23, 2024 3:27am
Gilead calls off Oceanside biologics expansion, moves team north
Jan 16, 2024 4:14pm
CAR-T hype faces infrastructure reality check
Jan 15, 2024 3:00am
Gilead cuts 7% of staff at Kite Pharma unit, refreshes strategy
Nov 29, 2023 8:01am
Gilead execs detail CAR-T outlook, barriers to uptake in the US
Nov 8, 2023 2:05pm